Artemether-lumefantrine dispersible
Access
-
Approved
Coartem® Dispersible
Novartis
Paediatric formulation
3-day cure, artemisinin-based combination therapies (TPP-1)
Therapeutic indication |
|
Dosing |
|
Efficacy |
|
Key features |
|
Challenges |
|
Status |
|
Project Director |
|